LEAD BOLDLY

IN CANCER RESEARCH

LEAD BRAVELY

IN CANCER RESEARCH

LEAD FEARLESSLY

IN CANCER RESEARCH

WE ARE TME

NEWS

TME IPEX Registry Investigator Cathy Graham presents poster on her experience with 469 patients at 2016 Annual American Society of Breast Surgery meeting in Dallas.

 

Upstage rates are markedly lower using BLES with U/S guidance (1.16%) than previously published data using large-gauge vacuum assisted core needle biopsy.  Results suggest that high risk lesions can be managed with BLES reducing the need for surgical intervention.

 

Intact Cathy Graham FINAL

Published in Publications

TME IPEX Registry Investigator Steve Schonholz presents poster at 2016 Annual American Society of Breast Surgery meeting in Dallas.

 

Retrospective data analysis demonstrates feasibility of complete excision of smaller cancer lesions sized 4-12mm using the INTACT Breast Lesion Excision System (BLES).  In 88% of cases complete excision was achieved, paving the way for minimally invasive management of small breast cancers. 

 

Schonholz ASBS FINAL

Published in Publications